蜜臀av性久久久久|国产免费久久精品99|国产99久久久久久免费|成人精品一区二区三区在线|日韩精品一区二区av在线|国产亚洲欧美在线观看四区|色噜噜综合亚洲av中文无码|99久久久国产精品免费播放器

<cite id="ygcks"><center id="ygcks"></center></cite>
  • 
    
  • <rt id="ygcks"></rt>
    <cite id="ygcks"></cite>
  • <li id="ygcks"><source id="ygcks"></source></li> <button id="ygcks"></button>
  • <button id="ygcks"></button>
    <button id="ygcks"><input id="ygcks"></input></button>
    
    
    <abbr id="ygcks"><source id="ygcks"></source></abbr>
    
    

    American scientists develop HIV vaccine for non-human primates

    Source: Xinhua| 2018-12-15 03:17:02|Editor: mmm
    Video PlayerClose

    WASHINGTON, Dec. 14 (Xinhua) -- American scientists have developed an experimental HIV vaccine strategy that works in non-human primates, which lends clues to identifying target and dosage for potential HIV vaccine for humans.

    The new study published on Friday in the journal Immunity showed that rhesus macaque monkeys can be prompted to produce neutralizing antibodies against one strain of HIV that resembles the resilient viral form that most commonly infects people, called a Tier 2 virus.

    "We found that neutralizing antibodies that have been induced by vaccination can protect animals against viruses that look a lot like real-world HIV," said Dennis Burton, chair of Scripps Research's Department of Immunology and Microbiology.

    Although the vaccine is far from human clinical trials, the study provided proof-of-concept for the HIV vaccine strategy Burton and his colleagues have been developing since the 1990s.

    The research also provided the first-ever estimate of vaccine-induced neutralizing antibody levels needed to protect against HIV.

    An effective vaccine strategy has to expose the immune system to the virus's outer envelope protein trimer, before producing the right antibodies against it. But the protein trimers tend to be unstable and fall apart when isolated, according to the study.

    The researchers genetically engineered a more stable trimer, or SOSIP, and designed an experimental HIV vaccine that contained this stable SOSIP trimer.

    The team tested the vaccine in two groups of rhesus macaques.

    A previous study using the same vaccine had shown that some immunized monkeys naturally developed low neutralizing antibody titers or antibody levels in their bodies, while others developed high titers following vaccination.

    From this study, the researchers selected and re-vaccinated six low titer monkeys and six high titer monkeys. They also used 12 unimmunized primates as their control group.

    The primates were then exposed to a form of the virus called SHIV, an engineered simian version of HIV that contains the same envelope trimer as the human virus.

    This particular strain of the virus is known as a Tier 2 virus because it has been shown to be hard to neutralize, much like the forms of HIV circulating in the human population.

    The researchers found that the vaccination worked in the high titer animals. The monkeys could produce sufficient levels of neutralizing antibodies against the envelope protein trimer to prevent infection.

    In tracking the antibody levels while continuously exposing animals to the virus, the researchers determined the titers needed to keep HIV at bay.

    Going forward, the scientists are looking to improve the vaccine design for human trials and keep titers high.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001376752461
    辽阳市| 兴义市| 余庆县| 儋州市| 蓬安县| 静安区| 河西区| 聂拉木县| 离岛区| 双流县| 泗洪县| 惠安县| 锡林浩特市| 岐山县| 达拉特旗| 梓潼县| 台山市| 新竹县| 托克托县| 海门市| 天长市| 新民市| 河津市| 林周县| 光泽县| 武宣县| 西吉县| 钟山县| 大丰市| 出国| 收藏| 新巴尔虎左旗| 金平| 临邑县| 多伦县| 邵东县| 尼勒克县| 天津市| 筠连县| 大冶市| 留坝县|